These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Non-pigmented rapidly growing mycobacteria smooth and rough colony phenotypes pathogenicity evaluated using in vitro and experimental models. García-Coca M, Aguilera-Correa JJ, Ibáñez-Apesteguía A, Rodríguez-Sevilla G, Romera-García D, Mahíllo-Fernández I, Reina G, Fernández-Alonso M, Leiva J, Muñoz-Egea MC, Del Pozo JL, Esteban J. Pathog Dis; 2019 Jul 01; 77(5):. PubMed ID: 31583400 [Abstract] [Full Text] [Related]
4. [Frequency and clinical relevance of rapidly growing mycobacterium isolated from respiratory samples]. Duan HF, Wang QF, Wang J, Wang J, Huang HR, Chu NH. Zhonghua Jie He He Hu Xi Za Zhi; 2016 Feb 01; 39(2):113-6. PubMed ID: 26879615 [Abstract] [Full Text] [Related]
5. Clinical and radiological features of pulmonary disease caused by rapidly growing mycobacteria in cancer patients. Jacobson K, Garcia R, Libshitz H, Whimbey E, Rolston K, Abi-Said D, Raad I. Eur J Clin Microbiol Infect Dis; 1998 Sep 01; 17(9):615-21. PubMed ID: 9832262 [Abstract] [Full Text] [Related]
6. [Evaluation of the distribution of non-tuberculous mycobacteria strains isolated in National Tuberculosis Reference Laboratory in 2009-2010, Turkey]. Albayrak N, Simşek H, Sezen F, Arslantürk A, Tarhan G, Ceyhan I. Mikrobiyol Bul; 2012 Oct 01; 46(4):560-7. PubMed ID: 23188570 [Abstract] [Full Text] [Related]
7. Topical ciprofloxacin for treating nontuberculous mycobacterial keratitis. Hu FR, Luh KT. Ophthalmology; 1998 Feb 01; 105(2):269-72. PubMed ID: 9479286 [Abstract] [Full Text] [Related]
8. Prevalence and species spectrum of both pulmonary and extrapulmonary nontuberculous mycobacteria isolates at a tertiary care center. Umrao J, Singh D, Zia A, Saxena S, Sarsaiya S, Singh S, Khatoon J, Dhole TN. Int J Mycobacteriol; 2016 Sep 01; 5(3):288-293. PubMed ID: 27847012 [Abstract] [Full Text] [Related]
9. In Vitro Antimicrobial Susceptibility of Nontuberculous Mycobacteria in Iran. Heidarieh P, Mirsaeidi M, Hashemzadeh M, Feizabadi MM, Bostanabad SZ, Nobar MG, Hashemi Shahraki A. Microb Drug Resist; 2016 Mar 01; 22(2):172-8. PubMed ID: 26468990 [Abstract] [Full Text] [Related]
10. Rapidly growing mycobacteria in King Chulalongkorn Memorial Hospital and review of the literature in Thailand. Phowthongkum P, Prasanthai V, Udomsantisook N, Suankratay C. J Med Assoc Thai; 2005 Aug 01; 88(8):1153-62. PubMed ID: 16404850 [Abstract] [Full Text] [Related]
11. Port-site infections by nontuberculous mycobacterium: A retrospective clinico-microbiological study. Ghosh R, Das S, De A, Kela H, Saha ML, Maiti PK. Int J Mycobacteriol; 2017 Aug 01; 6(1):34-37. PubMed ID: 28317802 [Abstract] [Full Text] [Related]
12. Mycobacterium fortuitum complex in Sweden during an 11-year period. Svahn A, Hoffner SE, Petrini B, Källenius G. Scand J Infect Dis; 1997 Aug 01; 29(6):573-7. PubMed ID: 9571737 [Abstract] [Full Text] [Related]
13. National atypical mycobacteria survey, 2000. Haverkort F, Australian Mycobacterium Reference Laboratory Network, Special Interest Group in Mycobacteria within the Australian Society for Microbiology. Commun Dis Intell Q Rep; 2003 Aug 01; 27(2):180-9. PubMed ID: 12926733 [Abstract] [Full Text] [Related]
14. Antimicrobial susceptibility testing of rapidly growing mycobacteria isolated in Japan. Hatakeyama S, Ohama Y, Okazaki M, Nukui Y, Moriya K. BMC Infect Dis; 2017 Mar 07; 17(1):197. PubMed ID: 28270102 [Abstract] [Full Text] [Related]
16. Clinical relevance of Mycobacterium chelonae-abscessus group isolation in 95 patients. van Ingen J, de Zwaan R, Dekhuijzen RP, Boeree MJ, van Soolingen D. J Infect; 2009 Nov 07; 59(5):324-31. PubMed ID: 19732795 [Abstract] [Full Text] [Related]
17. Utility of the MALDI-TOF MS method to identify nontuberculous mycobacteria. Kodana M, Tarumoto N, Kawamura T, Saito T, Ohno H, Maesaki S, Ikebuchi K. J Infect Chemother; 2016 Jan 07; 22(1):32-5. PubMed ID: 26603481 [Abstract] [Full Text] [Related]
18. Mycobacterium xenopi, Mycobacterium fortuitum, Mycobacterium kansasii, and other nontuberculous mycobacteria in an area of endemicity for AIDS. Shafer RW, Sierra MF. Clin Infect Dis; 1992 Jul 07; 15(1):161-2. PubMed ID: 1617056 [Abstract] [Full Text] [Related]
19. Catheter-related infections caused by the Mycobacterium fortuitum complex: 15 cases and review. Raad II, Vartivarian S, Khan A, Bodey GP. Rev Infect Dis; 1991 Jul 07; 13(6):1120-5. PubMed ID: 1775845 [Abstract] [Full Text] [Related]
20. Antimicrobial susceptibility of nontuberculous mycobacteria from eye infections. Brown-Elliott BA, Mann LB, Hail D, Whitney C, Wallace RJ. Cornea; 2012 Aug 07; 31(8):900-6. PubMed ID: 22362004 [Abstract] [Full Text] [Related] Page: [Next] [New Search]